ENDRA Life Sciences Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
ENDRA Life Sciences Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q3 2024.
  • ENDRA Life Sciences Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$845K, a 3094% decline year-over-year.
  • ENDRA Life Sciences Inc. annual Nonoperating Income (Expense) for 2023 was $460K.
  • ENDRA Life Sciences Inc. annual Nonoperating Income (Expense) for 2022 was -$21.5K, a 108% decline from 2021.
  • ENDRA Life Sciences Inc. annual Nonoperating Income (Expense) for 2021 was $267K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$845K -$873K -3094% Jul 1, 2024 Sep 30, 2024 10-Q/A 2024-11-21
Q2 2024 $1.7K -$436K -99.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q4 2023 $460K -$1.76K -$25.5K -107% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $486K $28.2K +$51.2K Jul 1, 2023 Sep 30, 2023 10-Q/A 2024-11-21
Q2 2023 $435K $437K +$457K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$22K -$3.42K -$485 -16.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$21.5K $23.8K +$56.9K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$78.4K -$23K -$15.5K -207% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$62.9K -$19.4K -$20.5K -1884% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$42.4K -$2.93K -$309K -101% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $267K -$33.1K -$36.7K -1024% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $304K -$7.51K -$4.89K -186% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $309K $1.09K +$3.68K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $305K $307K +$529K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$224K $3.58K +$1.68M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$1.91M -$2.62K +$770K +99.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.68M -$2.59K +$6.61K +71.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$2.68M -$222K -$220K -14531% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$2.46M -$1.68M -$1.32M -363% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$1.15M -$773K -$370K -91.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$777K -$9.2K +$14.5K +61.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$791K -$1.52K -$13.8K -112% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$777K -$363K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$403K -$405K -19994% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$23.7K +$351K +93.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $12.3K +$393K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q3 2017 $2.03K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$375K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$381K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.